A new study reports a novel combination of two targeted drugs dramatically slowed the growth of brain cancer tumors and significantly extended survival in mouse models.
Researchers discover the mTOR pathway is highly active in many cases of pediatric low-grade glioma. Blocking the pathway lead to a decreased growth of the brain tumors.
A new study could pave the way for more effective treatment of infantile ETMR/ETANTR brain cancer.
Recurrent gliomas could have genetic profiles which are different from those of the initial tumors that spawned them, a new study reports.
Researchers demonstrate melanoma differentiation associated gene, mda-9/syntenin is a driving force behind the aggressive and invasive nature of glioblastoma brain cancer.
A genetic mutation associated with a number of cancers could also be responsible for papillary craniopharyngioma, a rare but debilitating brain tumor, a new study reports.
Researchers find aspirin intake correlates with halted growth of vestibular schwannomas.